NRIX
Price
$16.83
Change
+$0.48 (+2.94%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.72B
76 days until earnings call
Intraday BUY SELL Signals
NUVB
Price
$8.37
Change
+$0.90 (+12.05%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
2.7B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs NUVB

Header iconNRIX vs NUVB Comparison
Open Charts NRIX vs NUVBBanner chart's image
Nurix Therapeutics
Price$16.83
Change+$0.48 (+2.94%)
Volume$32.27K
Capitalization1.72B
Nuvation Bio
Price$8.37
Change+$0.90 (+12.05%)
Volume$67.2K
Capitalization2.7B
NRIX vs NUVB Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
NUVB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. NUVB commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (NRIX: $16.35 vs. NUVB: $7.47)
Brand notoriety: NRIX and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 52% vs. NUVB: 21%
Market capitalization -- NRIX: $1.72B vs. NUVB: $2.7B
NRIX [@Biotechnology] is valued at $1.72B. NUVB’s [@Biotechnology] market capitalization is $2.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than NUVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while NUVB’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • NUVB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NRIX and NUVB are a good buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -3.82% price change this week, while NUVB (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

NUVB is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($2.7B) has a higher market cap than NRIX($1.72B). NUVB YTD gains are higher at: 180.827 vs. NRIX (-13.217). NUVB has higher annual earnings (EBITDA): -201.17M vs. NRIX (-248.7M). NUVB has more cash in the bank: 608M vs. NRIX (429M). NRIX (56.5M) and NUVB (57.8M) have identical debt. NRIX has higher revenues than NUVB: NRIX (83.7M) vs NUVB (14.4M).
NRIXNUVBNRIX / NUVB
Capitalization1.72B2.7B64%
EBITDA-248.7M-201.17M124%
Gain YTD-13.217180.827-7%
P/E RatioN/AN/A-
Revenue83.7M14.4M581%
Total Cash429M608M71%
Total Debt56.5M57.8M98%
TECHNICAL ANALYSIS
Technical Analysis
NRIXNUVB
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
85%
Momentum
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 6 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
NUVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMIX30.44N/A
N/A
Harding Loevner International Eq Instl
MXMTX11.21N/A
N/A
Empower Small Cap Growth Investor
ARRZX14.66N/A
N/A
AMG River Road Focused Absolute Value Z
AWWIX15.94N/A
N/A
CIBC Atlas International Growth Instl
MNSQX24.07N/A
N/A
Invesco Main Street Small Cap R5

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with FULC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then FULC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-5.20%
FULC - NUVB
45%
Loosely correlated
-9.27%
NRIX - NUVB
44%
Loosely correlated
-3.31%
IPSC - NUVB
41%
Loosely correlated
-2.62%
RCUS - NUVB
41%
Loosely correlated
-2.49%
VCYT - NUVB
40%
Loosely correlated
-0.43%
More